InsiderTrades

Form 4 for VKTX Viking Therapeutics, Inc.

Accepted 2026-01-05 00:00:00 ET · period of report 2026-01-02 · accession 0001193125-26-003115 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2026-01-05 2026-01-02 VKTX Mancini Marianna COO A - Grant $0.00 +73.0K 466.9K +19% $0
DM 2026-01-05 2026-01-05 VKTX Mancini Marianna COO S - Sale $32.97 -57.7K 409.2K -12% -$1.90M
D 2026-01-05 2026-01-02 VKTX Mancini Marianna COO A - Grant $0.00 +91.0K 91.0K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock, par value $0.00001 per share 2026-01-02 A A 41,000 $0.00 434,802 D — — (F1) Represents a restricted stock unit award ("RSU") of common stock under the Issuer's 2024 Equity Incentive Plan. One-third of the shares subject to the RSU shall vest on each one year anniversary of the grant date of the award. (F2) Includes 11,111 shares acquired on May 20, 2024 pursuant to the Issuer's 2014 Employee Stock Purchase Plan and 108 shares acquired on May 20, 2025 and 116 shares acquired on November 20, 2025 both pursuant to the Issuer's 2024 Employee Stock Purchase Plan.
2 Common Common Stock, par value $0.00001 per share 2026-01-02 A A 32,049 $0.00 466,851 D — — (F3) The reported securities were subject to a performance restricted stock unit award that was granted on January 3, 2023, 33.33% of which vested on January 2, 2026, upon the achievement of a non-financial performance goal and a second performance restricted stock unit award that was granted on January 3, 2025, 1.665% of which vested on January 2, 2026, upon the partial achievement of a non-financial performance goal.
3 Common Common Stock, par value $0.00001 per share 2026-01-05 S D 31,961 $32.29 434,890 D — — (F4) These shares were automatically sold on a non-discretionary basis solely to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of certain shares of common stock subject to certain restricted stock unit awards that vested on January 3, 2026 and the performance restricted stock unit awards described in Footnote 3. (F5) The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $31.87 to $32.86, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
4 Common Common Stock, par value $0.00001 per share 2026-01-05 S D 13,600 $33.37 421,290 D — — (F4) These shares were automatically sold on a non-discretionary basis solely to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of certain shares of common stock subject to certain restricted stock unit awards that vested on January 3, 2026 and the performance restricted stock unit awards described in Footnote 3. (F6) The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $32.87 to $33.86, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
5 Common Common Stock, par value $0.00001 per share 2026-01-05 S D 10,500 $34.22 410,790 D — — (F4) These shares were automatically sold on a non-discretionary basis solely to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of certain shares of common stock subject to certain restricted stock unit awards that vested on January 3, 2026 and the performance restricted stock unit awards described in Footnote 3. (F7) The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $33.87 to $34.85, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
6 Common Common Stock, par value $0.00001 per share 2026-01-05 S D 1,600 $35.07 409,190 D — — (F4) These shares were automatically sold on a non-discretionary basis solely to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of certain shares of common stock subject to certain restricted stock unit awards that vested on January 3, 2026 and the performance restricted stock unit awards described in Footnote 3. (F8) The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $34.88 to $35.20, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
7 Derivative Stock Option (Right to Buy) 2026-01-02 A A 91,000 $0.00 91,000 D $35.42 · — to 2036-01-02 91,000 Common Stock (F9) 25% of the shares subject to the option will vest on each anniversary of the grant date.